The Organ-on-Chip Center Twente (OoCCT) is a center of expertise supported by the MESA+ Institute and the TechMed Centre of the University of Twente. OoCCT brings together researchers interested in Organ-on-Chip to share their knowledge. The affiliated scientists, across all faculties, are encouraged to share their vision on the topic of Organs-on-Chips, discuss the latest developments in the field, explore practical collaborations and participate in writing research proposals. Equally important, OoCCT aims to provide services to researchers and companies outside of the University of Twente and give them access to the technology developed here in order to accelerate innovation and real-world application of Organs-on-Chips.
OoCCT has two scientific leads (Liliana Moreira Teixeira & Andries van der Meer) and a business lead (Berend van Meer)
At the University of Twente, we develop Organs-on-Chips to investigate the safety of health products and to understand the mechanisms of disease. We believe Organs-on-Chips will find widespread use in biomedical science and will progressively reduce the need for animal models as the mainstay in efficacy and toxicity testing. Connected to the Dutch Organ-on-Chip consortium “human Organ and Disease Model Technologies” (hDMT) and actively involved in the Netherlands Organ-on-Chip Initiative (NOCI), the Organ-on-Chip Center Twente is an important Dutch Organ-on-Chip partner in many projects. In addition, the University of Twente was involved in founding the European Organ-on-Chip Society (EUROoCS) to bring together Organ-on-Chip researchers internationally.
Researchers at the University of Twente are international leaders in key technological fields for Organ-on-Chip development, such as materials science, biofabrication, sensing, imaging, stem cell technology and tissue engineering. As a result, we play a leading role worldwide in the development of innovative Organs-on-Chips. By working with our strong network of biomedical, clinical and industrial partners, we apply our Organs-on-Chips in the development of personalized treatments for patients in many disease areas.